“Association of Serum Ferritin with Metabolic Syndrome, Insulin Resistance, Dyslipidemia, and Abdominal Obesity: A Systematic Review”. (2026) World Journal of Current Medical and Pharmaceutical Research, 8(3), pp. 318–322. doi:10.37022/wjcmpr.v8i3.477.